TrialBMJ (Clinical research ed.)2025

Effect of dapagliflozin on metabolic dysfunction-associated steatohepatitis: multicentre, double blind, randomised, placebo controlled trial.

Jiayang Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.